Skip to main content
. 2024 Jun 22;9(4):86. doi: 10.3390/geriatrics9040086

Figure 1.

Figure 1

Phase III drugs and molecules being tested for the treatment of Alzheimer’s disease applied at different sites in the neuronal cytoplasm.